For an 82‑year‑old female with insomnia, bipolar disorder, recurrent major depressive disorder, currently taking duloxetine 30 mg daily and trazodone 25 mg at bedtime, allergic to codeine, and experiencing anxiety and shakiness, should I increase trazodone and add buspirone twice daily as a non‑narcotic PRN anxiolytic?

Medication Management for Anxiety and Insomnia in an 82-Year-Old with Bipolar Disorder

I would not add buspirone for this patient's anxiety and shakiness, and would instead first optimize her existing regimen by increasing trazodone for insomnia while carefully evaluating whether her anxiety and tremor symptoms are actually adverse effects from duloxetine rather than undertreated anxiety.

Critical Safety Concerns in This Case

Evaluate Duloxetine as the Cause of Shakiness

• Duloxetine commonly causes tremor, nervousness, and anxiety as side effects, particularly in elderly patients 1.
• The patient's current dose of 30 mg daily is subtherapeutic for depression (standard dosing is 60 mg daily), yet may still be causing activating side effects 1.
• Before adding another medication, assess whether her "anxiety and shakiness" began or worsened after starting duloxetine 1.
• If duloxetine is contributing to these symptoms, consider switching to a less activating antidepressant rather than adding buspirone 1.

Buspirone Has Significant Limitations in This Context

• Buspirone requires 2-4 weeks to become effective and is not appropriate for PRN use 1.
• It is only useful for mild to moderate agitation, not acute anxiety relief 1.
• Buspirone is contraindicated or requires extreme caution with duloxetine due to significant drug interactions 2.
• The FDA label warns that combining buspirone with other serotonergic agents increases risk of adverse effects 2.

Bipolar Disorder Considerations

• In bipolar disorder, antidepressants (including duloxetine) carry risk of mood destabilization, particularly without a mood stabilizer 3.
• The patient's anxiety and agitation could represent emerging mixed features or hypomania rather than pure anxiety 4, 3.
• Trazodone at low doses (25-50 mg) has minimal risk of inducing mania in bipolar patients and is safer than most antidepressants 4.

Recommended Treatment Algorithm

Step 1: Increase Trazodone for Insomnia

• Increase trazodone from 25 mg to 50-100 mg at bedtime 1.
• The current 25 mg dose is subtherapeutic; elderly patients typically require 50-200 mg for insomnia 1.
• Trazodone is well-tolerated in elderly patients and addresses both insomnia and agitation 1, 5.
• Maximum dose can reach 200-400 mg daily if needed, though start conservatively 1.
• Recent guidelines suggest against trazodone 50 mg as monotherapy for insomnia, but support higher doses (100+ mg) or combination with mood stabilizers in bipolar depression 1.

Step 2: Reassess Duloxetine

• If anxiety and tremor persist after optimizing trazodone, consider reducing or discontinuing duloxetine 1.
• Duloxetine at 30 mg provides minimal antidepressant benefit but can cause activating side effects 1.
• Taper duloxetine over 10-14 days to avoid withdrawal syndrome 1.
• Alternative: If depression requires treatment, consider switching to a less activating agent like mirtazapine 7.5-15 mg at bedtime, which also improves sleep and is better tolerated in elderly patients 1.

Step 3: If Anxiety Persists After Above Adjustments

• For true anxiety requiring PRN treatment, short-term low-dose benzodiazepines are more appropriate than buspirone 1.
• Consider lorazepam 0.25-0.5 mg PRN (short half-life, no active metabolites, safer in elderly) 1.
• However, benzodiazepines should be avoided long-term in elderly patients due to fall risk, cognitive impairment, and dependence 1.
• If chronic anxiety treatment is needed after optimizing other medications, then buspirone 5 mg twice daily could be considered, but only as scheduled dosing, not PRN 1.

Key Clinical Pitfalls to Avoid

Do Not Use Buspirone PRN

• Buspirone has no immediate anxiolytic effect and cannot be used "as needed" 1.
• It requires consistent twice or three-times daily dosing for 2-4 weeks before efficacy 1.
• Patients expecting immediate relief will be disappointed and non-adherent 1.

Monitor for Drug Interactions

• Combining buspirone with duloxetine significantly increases buspirone levels and side effects 2.
• If buspirone must be used with duloxetine, start at 2.5 mg twice daily (not the standard 5 mg) 2.
• Watch for lightheadedness, dizziness, and somnolence with this combination 2.

Assess for Bipolar Mood Instability

• Anxiety and agitation in bipolar disorder may indicate inadequate mood stabilization rather than pure anxiety 4, 3.
• Consider whether this patient needs a mood stabilizer (lithium, valproate, or lamotrigine) rather than additional anxiolytics 1.
• Antidepressant monotherapy in bipolar disorder is generally inappropriate 3.

Age-Related Dosing Considerations

• All psychotropic medications require lower starting doses and slower titration in 82-year-old patients 1.
• Elderly patients have increased sensitivity to anticholinergic effects, orthostatic hypotension, and sedation 1.
• Trazodone can cause orthostatic hypotension; advise patient to rise slowly from lying/sitting 1, 6, 5.